InsidersTradesSigma
Discover the complete record of transactions filed by Yang Allen, Chairman & CEO. Director active across 1 companies, notably Xencor Inc. Aggregated, 4 reports have been published. Total volume traded: €269k. The latest transaction was disclosed on 9 March 2022 — Cession. Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Yang Allen is the President and Chief Executive Officer of Xencor Inc. He oversees the strategic operations of the company, focusing on the development of innovative therapies. His leadership and vision are essential in guiding Xencor to new heights in the biopharmaceutical sector.